For thick vascular lesions such as pyogenic granuloma, configure treatment around the lesion’s clinical endpoint and thermal response rather than relying on a fixed setting. With a CO2 laser, vaporize or photocoagulate progressively until the lesion becomes uniformly blanched and dusty gray, avoiding unnecessary extension into surrounding tissue. With a long-pulse 1064 nm Nd:YAG laser, commonly used starting ranges are 3–7 mm spot sizes, 20–50 ms pulse durations, and 100–250 J/cm², with lower fluences of approximately 60–100 J/cm² for larger spots; active cooling and a minimum 30-second interval between pulses are essential.
Thick vascular lesions require controlled treatment to a defined endpoint, followed by enough time for tissue cooling. Nd:YAG treatment should use conservative, non-overlapping pulses with mandatory cooling and rest intervals because excessive thermal accumulation increases the risk of necrosis and scarring.
Establish the Treatment Objective
Decide whether the goal is ablation or coagulation
CO2 lasers can remove a pyogenic granuloma through precise tissue vaporization while simultaneously coagulating small vessels. The operator should generally reduce the lesion toward the level of the surrounding skin rather than aggressively deepening the treatment field.
A defocused CO2 beam can provide broader thermal coagulation when bleeding occurs or when a deeper feeder vessel requires treatment. This mode should be used selectively because additional thermal spread increases collateral tissue injury.
Identify lesion thickness and vascular depth
Parameter selection should reflect the lesion’s diameter, elevation, depth, and feeder-vessel size. A thick, elevated lesion requires more attention to depth and heat diffusion than a superficial telangiectasia.
The appropriate endpoint is usually a visible tissue response such as uniform blanching, dusty-gray coagulation, or controlled lesion shrinkage, depending on whether the treatment is ablative or coagulative.
Configuring CO2 Laser Treatment
Use the clinical endpoint to guide energy delivery
For CO2 photocoagulation of a pyogenic granuloma, continue controlled treatment until the entire lesion blanches to a dusty gray color. This endpoint indicates substantial coagulation, but it does not justify indiscriminate additional passes.
For ablative treatment, supplementary references describe settings around 3–5 W with a 2–4 mm spot size, while other protocols use approximately 0.3–4.0 W in superpulsed or continuous modes at 5–10 Hz. These ranges are device- and technique-dependent and should be treated as protocol examples, not universal prescriptions.
Control depth and collateral heating
Keep the beam focused when vaporizing tissue and use a defocused beam only when broader coagulation is clinically required. The objective is to control bleeding or treat the vascular base without creating avoidable thermal damage in adjacent skin.
Local anesthesia is commonly appropriate for painful or elevated lesions. Eye protection, smoke evacuation, and the laser manufacturer’s tissue-specific safety guidance remain mandatory.
Plan staged treatment when needed
Repeated CO2 sessions may be scheduled at intervals of approximately 3–4 weeks when residual lesion tissue or recurrence requires additional treatment. The interval allows the treated area to heal and makes the next clinical assessment more reliable.
Configuring Long-Pulse 1064 nm Nd:YAG Treatment
Select spot size, fluence, and pulse duration together
For thick or deeper vascular lesions, a long-pulse Nd:YAG system is commonly configured within these broad ranges:
- Spot size: 3–7 mm
- Fluence: 100–250 J/cm²
- Pulse duration: 20–50 ms
- Lower-fluence approach for larger spots: approximately 60–100 J/cm²
The larger the spot, the more carefully fluence should be reduced because the delivered thermal load and penetration profile change with spot size. Settings should be titrated to the patient, lesion, device, and endpoint rather than selected from a range in isolation.
Match pulse duration to the target
A 20–50 ms pulse duration is consistent with treatment of relatively small or moderately sized vascular targets. Larger vessels may require longer pulses in some systems, but increasing pulse duration or fluence should be approached cautiously because thick lesions retain heat.
The underlying principle is to heat the vascular target sufficiently for coagulation while limiting thermal diffusion into surrounding dermis and epidermis.
Use cooling before and during irradiation
Surface cooling is mandatory when delivering high-fluence Nd:YAG pulses. Contact, cryogen-spray, or forced-air cooling may be used according to the device and protocol.
Cooling protects the epidermis and reduces pain, but it does not eliminate the need for conservative pulse spacing. A cooled surface can coexist with excessive heat accumulation deeper in the lesion.
Enforce a minimum rest interval
Allow at least 30 seconds between individual pulses to permit post-pulse tissue cooling. This delay is particularly important when treating thick lesions with high fluence, where residual heat may continue diffusing after the pulse ends.
Do not shorten the interval merely because the epidermis appears intact. Deep thermal injury and delayed scarring may develop despite limited immediate surface change.
Use Clinical Endpoints Safely
Look for controlled blanching or shrinkage
The desired response may include blanching, vasospasm, or visible lesion shrinkage, depending on the lesion and treatment objective. These signs should be assessed together with epidermal appearance and patient discomfort.
Excessive epidermal whitening, charring, blistering, or a rapidly expanding zone of thermal change suggests over-treatment. Stop and reassess rather than stacking additional pulses.
Avoid stacking and overlapping
Do not stack pulses on the same location. Adjacent spots should not overlap unless the device-specific protocol explicitly supports a controlled overlap, because cumulative heat can cause epidermal necrosis, dermal breakdown, and scarring.
For larger vascular targets, supplementary guidance recommends spacing treatment spots by at least 1 mm and keeping the repetition rate at or below approximately 1 Hz. These restrictions reinforce the need for deliberate pulse delivery rather than rapid scanning.
Account for anatomy and skin type
Facial telangiectasias generally require lower fluence than leg veins; supplementary guidance describes reducing fluence by approximately 30–40% for facial treatment. Thick pyogenic granulomas should still be assessed individually because lesion depth, location, and surrounding skin characteristics may dominate the setting choice.
Anesthesia should be considered for deep Nd:YAG coagulation because high-energy treatment can be painful and may otherwise encourage premature or inconsistent pulse delivery.
Understanding the Trade-offs
Higher energy improves coagulation but increases injury risk
Nd:YAG energy penetrates deeply and can treat larger-caliber vessels, but the same penetration creates a risk of deep thermal damage and post-treatment hyperpigmented scarring. High fluence is therefore not inherently better; it is useful only when the target requires it and the tissue can tolerate it.
CO2 treatment offers precise removal and intrinsic vessel sealing, but excessive ablation can deepen the wound and delay healing.
A single aggressive session is not always preferable
Staged CO2 treatment at 3–4-week intervals can be safer than attempting to eliminate all residual tissue in one aggressive session. Similarly, conservative Nd:YAG pulses with adequate cooling and rest may provide better control than rapid repeated exposure.
Recurrence may reflect an untreated feeder vessel or incomplete lesion control, not simply insufficient surface energy.
Published ranges are not interchangeable
CO2 power, spot size, pulse mode, and frequency vary substantially across systems. Nd:YAG fluence also depends on spot diameter, pulse shape, pulse duration, cooling method, lesion depth, and anatomic site.
These values should therefore be used as starting parameters within a validated clinical protocol, with test treatment and endpoint-based adjustment where appropriate.
How to Apply This to Your Project
Use a device-specific protocol and qualified clinical judgment to translate these ranges into treatment settings:
- If your primary focus is controlled CO2 ablation: Vaporize the lesion in a focused manner toward the surrounding skin level, using the dusty-gray blanching endpoint and avoiding unnecessary deep passes.
- If your primary focus is CO2 vascular coagulation: Use a defocused beam selectively for bleeding or deeper feeder vessels, while limiting thermal spread beyond the lesion base.
- If your primary focus is long-pulse Nd:YAG coagulation: Begin within the appropriate spot-size, fluence, and pulse-duration range, use mandatory surface cooling, and titrate to controlled blanching or shrinkage.
- If your primary focus is minimizing scarring: Never stack pulses, avoid overlapping spots, keep repetition at or below approximately 1 Hz, and maintain at least 30 seconds of cooling time between individual pulses.
The safest configuration is the lowest effective thermal dose that reaches the intended vascular endpoint while preserving surrounding skin.
Summary Table:
| Parameter | CO2 Laser | Long-Pulse Nd:YAG |
|---|---|---|
| Primary mode | Ablation or photocoagulation | Coagulation |
| Spot size | 2–4 mm (focused/defocused) | 3–7 mm |
| Fluence/Energy | 3–5 W or 0.3–4.0 W (superpulsed/CW) | 100–250 J/cm²; 60–100 J/cm² for large spots |
| Pulse duration | Varies (CW or superpulsed at 5–10 Hz) | 20–50 ms |
| Cooling | Smoke evacuation; not typically contact cooling | Mandatory surface cooling (contact, cryogen, or forced air) |
| Minimum interval between pulses | N/A (continuous or repetitive mode) | At least 30 seconds |
| Clinical endpoint | Dusty-gray blanching; controlled vaporization | Blanching, vasospasm, or shrinkage |
| Avoid | Deep passes into normal tissue | Stacking or overlapping pulses; high repetition rate (>1 Hz) |
For thick lesions, titrate settings to clinical response and allow adequate thermal relaxation to minimize scarring. Staged treatments at 3–4 week intervals may be needed.
Ready to enhance your clinic's laser protocols? BELIS provides professional-grade CO2 and long-pulse Nd:YAG systems designed for safe, effective treatment of thick vascular lesions. Our advanced technology ensures precise power delivery and integrated cooling, helping you achieve optimal outcomes while minimizing risks. Contact our experts today to explore how BELIS can elevate your aesthetic practice — request a consultation!
Related Products
- Fractional CO2 Laser Machine for Skin Treatment
- Fractional CO2 Laser Machine for Skin Treatment
- Cryolipolysis Fat Freezing Cavitation Lipo Laser Machine
- Cryolipolysis Fat Freezing Machine Cavitation Lipo Laser Machine
People Also Ask
- What is the technical principle behind CO2 Laser Fractional micro-perforations? Master Scar Revision Mechanics
- What parameters and treatment intervals are advised when applying fractional CO2 laser technology to delicate periorbital skin laxity? Discover safe protocols for eyelid rejuvenation.
- How do energy-based modalities complement injectable neurotoxins in décolleté rejuvenation? Explore synergistic benefits.
- What is the primary function of a high-precision fractional CO2 laser system for GSM? Restore Vaginal Health Naturally
- Why do fractional CO2 laser parameters need to be differentiated? Master Keloid vs. Hypertrophic Scar Treatment
